Francine Ntoumi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Francine Ntoumi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Balthazar Phoba
Centre de Formation et d’Appui Sanitaire (CEFA), Mont-Ngafula, Kinshasa BP 817, Democratic Republic of the Congo
1 shared publication - Daniel Parzy
Defideva/Altadeva—Biological Lab (Inpack), Luminy Biotech, 13009 Marseille, France
1 shared publication - Destin Mbongi
Centre de Formation et d’Appui Sanitaire (CEFA), Mont-Ngafula, Kinshasa BP 817, Democratic Republic of the Congo
1 shared publication - Jean-Paul Gonzalez
Department of Microbiology and Immunology, Division of Biomedical Graduate Research Organization, School of Medicine, Georgetown University, Washington, DC, USA
1 shared publication - Line Lobaloba Ingoba
Fondation Congolaise pour la Recherche Médicale (FCRM), Brazzaville, Republic of Congo
1 shared publication - Léon Tshilolo
Centre Hospitalier Monkole, Kinshasa, Congo (The Democratic Republic of the)
1 shared publication
Latest Publications
- Open Access
Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Central and West African Populations
For more than two years after the emergence of COVID-19 (Coronavirus Disease-2019), significant regional differences in morbidity persist. These differences clearly show lower incidence rates in several regions of the African and Asian continents. The work reported here aimed to test the hypothesis of a pre-pandemic natural immunity acquired by some human populations in central and western Africa, which would, therefore, pose the hypothesis of an original antigenic sin with a virus antigenically close to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). To identify such pre-existing immunity, sera samples collected before the emergence of COVID-19 were tested to detect the presence of IgG reacting antibodies against SARS-CoV-2 proteins of major significance. Sera samples from French blood donors collected before the pandemic served as a control. The results showed a statistically significant difference of antibodies prevalence between the collected samples in Africa and the control samples collected in France. Given the novelty of our results, our next step consists in highlighting neutralizing antibodies to evaluate their potential for pre-pandemic protective acquired immunity against SARS-CoV-2. In conclusion, our results suggest that, in the investigated African sub-regions, the tested populations could have been potentially and partially pre-exposed, before the COVID-19 pandemic, to the antigens of a yet non-identified Coronaviruses.
Open AccessPre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Central and West African Populations
For more than two years after the emergence of COVID-19 (Coronavirus Disease-2019), significant regional differences in morbidity persist. These differences clearly show lower incidence rates in several regions of the African and Asian continents. The work reported here aimed to test the hypothesis of a pre-pandemic natural immunity acquired by some human populations in central and western Africa, which would, therefore, pose the hypothesis of an original antigenic sin with a virus antigenically close to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). To identify such pre-existing immunity, sera samples collected before the emergence of COVID-19 were tested to detect the presence of IgG reacting antibodies against SARS-CoV-2 proteins of major significance. Sera samples from French blood donors collected before the pandemic served as a control. The results showed a statistically significant difference of antibodies prevalence between the collected samples in Africa and the control samples collected in France. Given the novelty of our results, our next step consists in highlighting neutralizing antibodies to evaluate their potential for pre-pandemic protective acquired immunity against SARS-CoV-2. In conclusion, our results suggest that, in the investigated African sub-regions, the tested populations could have been potentially and partially pre-exposed, before the COVID-19 pandemic, to the antigens of a yet non-identified Coronaviruses.